AI assistant
Sending…
BIO-TECHNE Corp — Director's Dealing 2024
Apr 5, 2024
30718_dirs_2024-04-05_80adf6b7-3391-4e73-aa71-01798988f862.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2024-04-03
Reporting Person: Bohnen Shane (SVP - General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-04-03 | Common Stock | M | 2259 | — | Acquired | 2394 | Direct |
| 2024-04-03 | Common Stock | F | 747 | $67.87 | Disposed | 1647 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-04-03 | Restricted Stock Units | $ | M | 2259 | Disposed | Common Stock (2259) | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F2: 2,260 restricted stock units vest on 4/3/25 and 2,259 restricted stock units vest on 4/3/26.
More from BIO-TECHNE Corp
Regulatory Filings
2026
Jun 1
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 19
Board/Management Information
2026
Feb 11
Director's Dealing
2026
Feb 5
Interim / Quarterly Report
2026
Feb 4